After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of CRISPR Therapeutics AG is $5.53B. A total of 1.9 million shares were traded on the day, compared to an average of 2.23M shares.
In the most recent transaction, RAJU PRASAD bought 29,700 shares of CRSP for 60.16 per share on Jan 06 ’26. In a previous transaction on Dec 22 ’25, Prasad Raju sold 10,000 shares at 55.95 per share. CRSP shares that Chief Financial Officer owns now total 6,767.
Among the insiders who bought shares, RAJU PRASAD acquired of 10,000 shares on Dec 22 ’25 at a per-share price of $55.95. In another insider transaction, Kulkarni Samarth sold 50,895 shares at $67.91 per share on Oct 17 ’25. Company shares held by the Chief Executive Officer now total 254,201.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, CRSP has a high of $78.48 and a low of $30.04.
As of this writing, CRSP has an earnings estimate of -$1.23 per share for the current quarter. EPS was calculated based on a consensus of 17.0 estimates, with a high estimate of -$0.98 per share and a lower estimate of -$1.67. The company reported an EPS of -$0.44 in the last quarter
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. CRSP’s latest balance sheet shows that the firm has $2.38B in Cash & Short Term Investments as of fiscal 2021. There were $225.03M in debt and $119.88M in liabilities at the time. Its Book Value Per Share was $20.41, while its Total Shareholder’s Equity was $2.40B.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CRSP is Buy with a score of 4.03.
